Next 10 |
(NewsDirect) Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. Dr Muehler noted that Immunic focuses on translating research ideas into clinical trials to demons...
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. Muehler explained that IBD encompasses Crohn's disease and ulcerative colitis, characterised ...
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease and the company’s developments in treating it. Kohlhof explai...
--News Direct-- Immunic Inc (NASDAQ:IMUX) CEO Dr Daniel Vitt takes Proactive's Stephen Gunnion through the company's first-quarter achievements and upcoming milestones for its clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseas...
2024-05-08 14:20:08 ET Immunic, Inc. (IMUX) Q1 2024 Earnings Conference Call May 08, 2024 08:00 AM ET Company Participants Jessica Breu - Vice President, Investor Relations & Communications Daniel Vitt - Chief Executive Officer, President & Director Glenn...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...
2024-05-08 06:34:45 ET More on Immunic Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript Brookline Capital starts Immunic at buy, cites MS drug candidate Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial...
Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update PR Newswire – Substantially Bolstered Balance Sheet Through a Three-Tranche Private Placement Totaling Up to $240 Million , Extending Cash Runway Into the Third Quarter of 2025,...
2024-05-07 14:13:32 ET More on Immunic Immunic, Inc. (IMUX) Q4 2023 Earnings Call Transcript Brookline Capital starts Immunic at buy, cites MS drug candidate Seeking Alpha’s Quant Rating on Immunic Historical earnings data for Immunic Financial...
2024-05-07 11:00:00 ET Major earnings expected before the bell on Wednesday include: Brookfield Asset Management ( BAM ) Emerson Electric ( EMR ) Shopify ( SHOP ) Teva Pharmaceutical Industries ( TEVA ) Uber Technologies ( UBER ) Read the fu...
News, Short Squeeze, Breakout and More Instantly...
Immunic Inc. Company Name:
IMUX Stock Symbol:
NYSE Market:
(NewsDirect) Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses the importance of clinical trials in the biotech industry to mark Clinical Trials Day on May 20. Dr Muehler noted that Immunic focuses on translating research ideas into clinical trials to demons...
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief medical officer Dr Andreas Muehler discusses Inflammatory Bowel Disease (IBD) with Proactive's Stephen Gunnion to mark World IBD Day on May 19. Muehler explained that IBD encompasses Crohn's disease and ulcerative colitis, characterised ...
--News Direct-- Immunic Inc (NASDAQ:IMUX) chief scientific officer Hella Kohlhof joined Proactive's Stephen Gunnion on International Celiac Day, in the middle of Celiac Disease Awareness Month, to discuss the disease and the company’s developments in treating it. Kohlhof explai...